ixInsights 2025: Unpacking the ixlayer & Ipsos report

As digital transformation accelerates across healthcare, patients are becoming increasingly discerning about how – and from whom – they expect meaningful support. The 2025 ixInsights report, commissioned by ixlayer and conducted by Ipsos, sheds light on the evolving expectations patients have for their digital health experience, and, critically, the role biopharma companies can play in enhancing it.

Based on survey responses from 414 U.S. adults living with chronic conditions such as asthma, COPD, type 2 diabetes, heart disease, psoriasis, and atopic dermatitis, the study outlines both the opportunities and challenges facing the industry. The data is especially relevant to those working in pharma marketing, digital strategy, and patient engagement.

A Digital Shift That’s Now Table Stakes

The survey found that digital health tools are no longer “nice to have” – they are expected.

• 92% of respondents report using patient portals

• 82% have accessed telehealth platforms

• 67% utilize pharmacy delivery services

• 86% of those who interacted with healthcare in the past year used at least one digital health solution

Satisfaction with digital tools hinges on three primary factors: convenience (68%), improved communication (55%), and faster access to care (44%).

Yet, despite growing adoption, one in four patients still avoid seeking care because it’s inconvenient, underscoring persistent systemic barriers.

The Fractured State of Digital Healthcare

Digital health may be...